NIH-funded research NIH-funded research

Understanding how BIN1 affects brain cell function in Alzheimer's disease

Official title: Unlocking BIN1 function in oligodendrocytes and support of axon integrity

Funded at Texas A&m Agrilife Research · NIH-10901005 · Data updated 2026-11-12

This study is looking at how a protein called BIN1 affects brain cells that help keep nerve fibers healthy, to see if changes in these cells might play a role in the early stages of Alzheimer's disease, even before symptoms show up.

Quick facts

Grant typeNIH-funded research
Study typeNIH-funded research
Funding institutionTexas A&m Agrilife Research
NIH-funded
Lab location1 site (College Station, UNITED STATES)
Project startSeptember 15, 2023
Project endAugust 31, 2025
Funding year2023
Award (this year)$466,531
NIH project number1R56AG083942-01
Project IDNIH-10901005 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are adults aged 21 and older who are at risk for or diagnosed with late-onset Alzheimer's disease.

Less likely to help

Patients with early-onset Alzheimer's disease or those without any cognitive impairment may not benefit from this research.

What this research studies

This research investigates the role of a protein called BIN1 in oligodendrocytes, which are cells that support the health of nerve fibers in the brain. The study focuses on how changes in these cells may contribute to the early stages of Alzheimer's disease, particularly before the more recognizable symptoms appear. By examining the cellular mechanisms involved, the researchers aim to uncover how BIN1 influences the integrity of axons, the long projections of nerve cells that are crucial for communication in the brain. This could lead to new insights into the disease process and potential therapeutic targets.

Why it matters

Potential benefit: If successful, this research could lead to new strategies for preventing or treating Alzheimer's disease by targeting the underlying cellular mechanisms involved in nerve cell health.

How similar studies have gone: While the specific role of BIN1 in oligodendrocytes is less explored, similar research has shown that targeting cellular mechanisms in neurodegenerative diseases can yield promising results.

Where this research is happening

  • Texas A&m Agrilife Research
    College Station, United States
    Active

Researchers

  • Principal investigator: Li, Jianrong — Texas A&m Agrilife Research
  • Study coordinator: Li, Jianrong

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.